In squamous cell carcinoma of the larynx, the population of epithelial cells in the tumor tissue is initially heterogeneous and, in addition to tumor cells invading the organ mucosa, includes normal epithelial cells of protein-mucous glands and cells of the stratified epithelium covering the mucous membrane. A search for differential markers to separate these subpopulations was carried out. The surface marker CD44 and cytokeratins 5 and 17 that are often used to verify carcinoma cells, are common markers for all epithelial cells of the larynx. In highly differentiated carcinoma, subpopulations of normal and tumor epithelial cells can be separated by the level of expression of cytokeratins 10 and 18 and nuclear markers Ki-67 and p63. However, in moderately differentiated carcinoma, tumor cells and normal cells of the basal layer of the stratified epithelium covering the mucous membrane of the larynx have similar phenotypes, which should be taken into account when conducting experimental studies.
Similar content being viewed by others
References
Ali AA, Al-Jandan BA, Suresh CS. The importance of ctokeratins in the early detection of oral squamous cell carcinoma. J. Oral Maxillofac. Pathol. 2018;22(3):441. https://doi.org/10.4103/jomfp.JOMFP_238_17
Borba M, Cernea C, Dias F, Faria P, Bacchi C, Brandão L, Costa A. Expression profile of p63 in 127 patients with laryngeal squamous cell carcinoma. ORL J. Otorhinolaryngol. Relat. Spec. 2010;72(6):319-324. https://doi.org/10.1159/000319904
Canning M, Guo G, Yu M, Myint C, Groves MW, Byrd JK, Cui Y. Heterogeneity of the head and neck squamous cell carcinoma immune landscape and its impact on immunotherapy. Front. Cell Dev. Biol. 2019;7:52. https://doi.org/10.3389/fcell.2019.00052
Caruntu A, Moraru L, Lupu M, Ciubotaru DA, Dumitrescu M, Eftimie L, Hertzog R, Zurac S, Caruntu C, Voinea OC. Assessment of histological features in squamous cell carcinoma involving head and neck skin and mucosa. J. Clin. Med. 2021;10(11):2343. https://doi.org/10.3390/jcm10112343
Chatzkel J, Lewis JS Jr, Ley JC, Wildes TM, Thorstad W, Gay H, Daly M, Jackson R, Rich J, Paniello R, Nussenbaum B, Liu J, Siegel BA, Dehdashti F, Adkins D. Correlation of Ki-67 proliferative antigen expression and tumor response to induction chemotherapy containing cell cycle-specific agents in head and neck squamous cell carcinoma. Head Neck Pathol. 2017;11(3):338-345. https://doi.org/10.1007/s12105-016-0775-9
Chen J, Zhou J, Lu J, Xiong H, Shi X, Gong L. Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis. BMC Cancer. 2014;14:15. https://doi.org/10.1186/1471-2407-14-15
Cirillo N, Wu C, Prime SS. Heterogeneity of cancer stem cells in tumorigenesis, metastasis, and resistance to antineoplastic treatment of head and neck tumours. Cells. 2021;10(11):3068. https://doi.org/10.3390/cells10113068
Demers I, Donkers J, Kremer B, Speel EJ. Ex vivo culture models to indicate therapy response in head and neck squamous cell carcinoma. Cells. 2020;9(11):2527. https://doi.org/10.3390/cells9112527
Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C. p63 expression profiles in human normal and tumor tissues. Clin. Cancer Res. 2002;8(2):494-501.
Fischer AH, Jacobson KA, Rose J, Zeller R. Preparation of Cells and Tissues for Fluorescence Microscopy. Basic Methods in Microscopy. Spector D, Goldman R, eds. New York, 2006. P. 103-123.
Gunti S, Hoke ATK, Vu KP, London NR Jr. Organoid and spheroid tumor models: techniques and applications. Cancers (Basel). 2021;13(4):874. https://doi.org/10.3390/cancers13040874
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Primers. 2020;6(1):92. https://doi.org/10.1038/s41572-020-00224-3
Kumar V, Vashishta M, Kong L, Wu X, Lu JJ, Guha C, Dwarakanath BS. The Role of Notch, Hedgehog, and Wnt signaling pathways in the resistance of tumors to anticancer therapies. Front. Cell Dev. Biol. 2021;9:650772. https://doi.org/10.3389/fcell.2021.650772
Kürten CHL, Kulkarni A, Cillo AR, Santos PM, Roble AK, Onkar S, Reeder C, Lang S, Chen X, Duvvuri U, Kim S, Liu A, Tabib T, Lafyatis R, Feng J, Gao SJ, Bruno TC, Vignali DAA, Lu X, Bao R, Vujanovic L, Ferris RL. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat. Commun. 2021;12(1):7338. https://doi.org/10.1038/s41467-021-27619-4
La Fleur L, Johansson AC, Roberg K. A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial–mesenchymal transition phenotype and resistance to treatment. PLoS One. 2012;7(9):e44071. https://doi.org/10.1371/journal.pone.0044071
Major AG, Pitty LP, Farah CS. Cancer stem cell markers in head and neck squamous cell carcinoma. Stem Cells Int. 2013;2013:319489. https://doi.org/10.1155/2013/319489
Menz A, Weitbrecht T, Gorbokon N, Büscheck F, Luebke AM, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Weidemann S, Fraune C, Möller K, Bernreuther C, Lebok P, Clauditz T, Sauter G, Uhlig R, Wilczak W, Steurer S, Minner S, Burandt E, Krech R, Dum D, Krech T, Marx A, Simon R. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors. Mol. Med. 2021;27(1):16. https://doi.org/10.1186/s10020-021-00274-7
Mestrinho LA, Pissarra H, Faísca PB, Bragança M, Peleteiro MC, Niza MM. p63 and E-cadherin expression in canine oral squamous cell carcinoma. Vet. Pathol. 2015;52(4):614-620. https://doi.org/10.1177/0300985814547391
Sharaf K, Lechner A, Haider SP, Wiebringhaus R, Walz C, Kranz G, Canis M, Haubner F, Gires O, Baumeister P. Discrimination of cancer stem cell markers ALDH1A1, BCL11B, BMI-1, and CD44 in different tissues of HNSCC patients. Curr. Oncol. 2021;28(4):2763-2774. https://doi.org/10.3390/curroncol28040241
Steurer S, Riemann C, Büscheck F, Luebke A.M, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Weidemann S, Fraune C, Möller K, Menz A, Fisch M, Rink M, Bernreuther C, Lebok P, Clauditz TS, Sauter G, Uhlig R, Wilczak W, Dum D, Simon R, Minner S, Burandt E, Krech R, Krech T, Marx AH. p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors. Biomark. Res. 2021;9(1):7. https://doi.org/10.1186/s40364-021-00260-5
Svobodova M, Raudenska M, Gumulec J, Balvan J, Fojtu M, Kratochvilova M, Polanska H, Horakova Z, Kostrica R, Babula P, Heger Z, Masarik M. Establishment of oral squamous cell carcinoma cell line and magnetic bead-based isolation and characterization of its CD90/CD44 subpopulations. Oncotarget. 2017;8(39):66 254-66 269. https://doi.org/10.18632/oncotarget.19914
Tanaka N, Osman AA, Takahashi Y, Lindemann A, Patel AA, Zhao M, Takahashi H, Myers JN. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.Oral Oncol. 2018;87:49-57. https://doi.org/10.1016/j.oraloncology.2018.10.018
Vasca V, Vasca E, Freiman P, Marian D, Luce A, Mesolella M, Caraglia M, Ricciardiello F, Duminica T. Keratin 5 expression in squamocellular carcinoma of the head and neck. Oncol. Lett. 2014;8(6):2501-2504. https://doi.org/10.3892/ol.2014.2591
WHO Report On Cancer: Setting Priorities, Investing Wisely and Providing Care for All. World Health Organization, 2020. URL: https://apps.who.int/iris/handle/10665/330745.
Xu ES, Yang MH, Liu CY, Liu KW, Yang TT, Chou TY, Hwang TZ, Hsu CT. Decreasing cytokeratin 17 expression in head and neck cancer predicts nodal metastasis and poor prognosis: The first evidence. Clin. Otolaryngol. 2018;43(4):1010-1018. https://doi.org/10.1111/coa.13092
Yi CH, Jim Zhai Q, Wang BY. Updates on immunohistochemical and molecular markers in selected head and neck diagnostic problems. Arch. Pathol. Lab. Med. 2017;141(9):1214-1235. https://doi.org/10.5858/arpa.2016-0245-RA
Yoh K, Prywes R. Pathway regulation of p63, a director of epithelial cell fate. Front. Endocrinol. (Lausanne). 2015;6:51. https://doi.org/10.3389/fendo.2015.00051
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 2, pp. 109-116, June, 2022
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Arutyunyan, I.V., Soboleva, A.G., Gordon, K.B. et al. Differential Markers of Subpopulations of Epithelial Cells of the Larynx in Squamous Cell Carcinoma. Bull Exp Biol Med 173, 553–559 (2022). https://doi.org/10.1007/s10517-022-05588-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-022-05588-y